Skip to main content
. 2023 Sep 20;14:1247253. doi: 10.3389/fphar.2023.1247253

TABLE 5.

Treatments and outcomes of HIT induced by LMWHs.

Parameter Value Percentage (%)
Treatment
Withdraw LMWHs (n = 43) 43 100.00
Surgical thrombectomy (n = 43) 6 13.95
Emergency treatment (n = 43) 1 2.33
Other relevant therapeutic drugs
Other anticoagulants (n = 39)
Fondaparinux 17 43.59
Lepirudin 11 28.21
Argatroban 7 17.95
Warfarin 5 12.82
Acenocoumarol 5 12.82
Rivaroxaban 4 10.26
Apixaban 2 5.13
Dabigatran 1 2.56
Clopidogrel 1 2.56
Platelet transfusion (n = 43) 2 4.65
Thrombolytic agent (n = 43) 1 2.33
Glucocorticoid (n = 43) 1 2.33
PLT recovery time (n = 34)
<5 days 9 26.47
 Nadroparin 4 11.76
 Enoxaparin 3 8.82
 Dalteparin 2 5.88
5–10 days 17 50.00
 Enoxaparin 11 32.35
 Nadroparin 4 11.76
 Bemiparin 1 2.94
 Tinzaparin 1 2.94
>10 days 8 23.53
 Nadroparin 5 14.71
 Enoxaparin 2 5.88
 Bemiparin 1 2.94
Prognosis (n = 43)
Recovery 41 95.35
Worse 1 2.33
Death 1 2.33